(Q38215452)

31 August 2017

Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes (English)

1 reference

31 August 2017

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24867662%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

A Avogaro

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24867662%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A Dardano

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24867662%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

S V de Kreutzenberg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24867662%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

25 June 2014

1 reference

Diabetes, Obesity and Metabolism

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24867662%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24867662%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24867662%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

107-115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24867662%20AND%20SRC:MED&resulttype=core&format=json

The dynamics of life expectancy over the last six decades in elderly people with diabetes.

5 June 2020

cites work

1 reference

Revision of the ADA-classification of diabetes mellitus type 2 (DMT2): the importance of maturity onset diabetes (MOD), and senile diabetes (DS).

21 January 2018

1 reference

Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006

21 January 2018

1 reference

Frailty in elderly people

21 January 2018

1 reference

Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis

21 January 2018

1 reference

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus

21 January 2018

1 reference

Better glycemic control is associated with maintenance of lower-extremity function over time in Mexican American and European American older adults with diabetes

21 January 2018

1 reference

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial

21 January 2018

1 reference

Hospitalization and discharge education of emergency department patients with hypoglycemia.

21 January 2018

1 reference

Oral antidiabetic treatment in type-2 diabetes in the elderly: balancing the need for glucose control and the risk of hypoglycemia

21 January 2018

1 reference

The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control

21 January 2018

1 reference

Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities

21 January 2018

1 reference

Symptoms of hypoglycaemia in people with diabetes

21 January 2018

1 reference

Cardiac implications of hypoglycaemia in patients with diabetes - a systematic review

21 January 2018

1 reference

Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring

21 January 2018

1 reference

QT interval, cardiovascular risk factors and risk of death in diabetes

21 January 2018

1 reference

Vascular disease and diabetes: is hypoglycaemia an aggravating factor?

21 January 2018

1 reference

Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes

21 January 2018

1 reference

Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia.

21 January 2018

1 reference

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

Increased mortality of patients with diabetes reporting severe hypoglycemia

21 January 2018

1 reference

Variations in tissue selectivity amongst insulin secretagogues: a systematic review

21 January 2018

1 reference

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

21 January 2018

1 reference

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study

21 January 2018

1 reference

Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

Effect of hypoglycemic agents on ischemic preconditioning in patients with type 2 diabetes and symptomatic coronary artery disease.

21 January 2018

1 reference

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

21 January 2018

1 reference

Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study.

21 January 2018

1 reference

Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial data

21 January 2018

1 reference

Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data.

21 January 2018

1 reference

Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial

21 January 2018

1 reference

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

21 January 2018

1 reference

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

21 January 2018

1 reference

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

21 January 2018

1 reference

21 January 2018

Diabetes in older adults

1 reference

Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diab

21 January 2018

1 reference

Are current clinical trials in diabetes addressing important issues in diabetes care?

21 January 2018

1 reference

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum

21 January 2018

1 reference

Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review

21 January 2018

1 reference

Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

A critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risks

21 January 2018

1 reference

Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors

21 January 2018

1 reference

Antidiabetic oral treatment in older people: does frailty matter?

21 January 2018

1 reference

Incretin therapies in the management of elderly patients with type 2 diabetes mellitus

21 January 2018

1 reference

Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks?

21 January 2018

1 reference

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus

21 January 2018

1 reference

Alogliptin use in elderly people: a pooled analysis from phase 2 and 3 studies

21 January 2018

1 reference

Efficacy and safety of linagliptin in subjects with type 2 diabetes mellitus and poor glycemic control: pooled analysis of data from three placebo-controlled phase III trials.

21 January 2018

1 reference

Clinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trials

21 January 2018

1 reference

Experience with vildagliptin in patients ≥75 years with type 2 diabetes and moderate or severe renal impairment

21 January 2018

1 reference

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

21 January 2018

1 reference

Linagliptin added to sulphonylurea in uncontrolled type 2 diabetes patients with moderate-to-severe renal impairment

21 January 2018

1 reference

Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease

21 January 2018

1 reference

Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial.

21 January 2018

1 reference

Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Efficacy of antihyperglycemic therapies and the influence of baseline hemoglobin A(1C): a meta-analysis of the liraglutide development program

21 January 2018

1 reference

Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.

21 January 2018

1 reference

Second-line agents for glycemic control for type 2 diabetes: are newer agents better?

21 January 2018

1 reference

Treatment of elderly patients with type 2 diabetes mellitus: a systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitors

21 January 2018

1 reference

Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types

21 January 2018

1 reference

The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

21 January 2018

1 reference

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

21 January 2018

1 reference

Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality.

21 January 2018

1 reference

The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepiride

21 January 2018

1 reference

DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats

21 January 2018

1 reference

DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption.

21 January 2018

1 reference

Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice.

21 January 2018

1 reference

Cognitive and functional influences of vildagliptin, a DPP-4 inhibitor, added to ongoing metformin therapy in elderly with type 2 diabetes

21 January 2018

1 reference

Effects of sitagliptin beyond glycemic control: focus on quality of life

21 January 2018

1 reference

Physiological disturbances in hypoglycaemia: Effect on subjective awareness

21 January 2018

1 reference

Altered Hierarchy of Protective Responses Against Severe Hypoglycemia in Normal Aging in Healthy Men

21 January 2018

1 reference

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD009008.PUB2

12 January 2024

Identifiers

DOI

10.1111/DOM.12319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24867662%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference